Better Biotech Stock: Moderna vs. BioNTech

·5 min read
Better Biotech Stock: Moderna vs. BioNTech

Not only did they develop the first two COVID vaccines authorized by the Food and Drug Administration, they used messenger RNA (mRNA). The technology had never been approved for a vaccine in humans. Moderna went public in 2018 in what was to that point the largest biotech initial public offering (IPO) in history.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting